Sirnaomics nabs $47 mln

Gaithersburg, Maryland-based Sirnaomics Inc, a biopharmaceutical company focused on RNAi therapeutics against cancer and fibrotic diseases, has raised $47 million in funding. The investors included CR-CP Life Sciences Fund, Rich Yield Capital, Rolling Boulder Investment and Legend Sky Investment.

Source: Press Release